4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001584759-26-000015
Director sold 13,100 shares at $12.02 ($157,462)
- Director acquired 3,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Heyman Richard A. · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-24 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,500 | $1.60 | $5,600 | 45,300 | D |
| 2026-07-24 | Sale : show line 2 in the form 10b5-1 | −7,000 | $12.02 | $84,140 | 38,300 | D |
| 2026-07-24 | Sale : show line 3 in the form 10b5-1 | −6,100 | $12.02 | $73,322 | 206,672 | I |
| Open-market sales · 13,100 sh · avg $12.02 · $157,462 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-24 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) | −3,500 | 30,200 | D |
Loading xslF345X06/form4-07282026_080709.xml…